Premium
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three‐month prospective study
Author(s) -
Ghazanfar Misbah Noshela,
Bartko Ewa Anna,
Arildsen Nicolai Skovbjerg,
Poulsen Lars K.,
Jensen Bettina Margrethe,
Enevold Christian,
Holm Jesper Grønlund,
Woetmann Anders,
Ødum Niels,
Thomsen Simon Francis
Publication year - 2022
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.14121
Subject(s) - omalizumab , medicine , immunoglobulin e , prospective cohort study , antihistamine , gastroenterology , antibody , immunology